Intelligent Pharma receives a capital injection of 550,000 euros and opens its 5h international office in Munich

by Parc Científic de Barcelona

8 years ago
Capital injection, Intelligent Pharma, computational chemistry, public investor

The company recently received a capital injection of 550,000 euros from the Avanza 2 program from the Ministry of Industry, Energy and Tourism, and the Torres Quevedo call from the Ministry of Economy...

A new era of research in cancer genomics

by Parc Científic de Barcelona

8 years ago
cancer, genomics, somatic mutations

A study published in the prestigious journal Nature Communications –led by the Centro Nacional de Analisis Genómico (CNAG-CRG), located at the Barcelona Science Park (PCB), and the German Cancer R...

Artax Biopharma Raises $10M Series B to fund Phase Ib-IIa clinical trials for AX-024, a novel oral treatment for autoimmune diseases and to further develop its pipeline of preclinical candidates

by Parc Científic de Barcelona

9 years ago
Advent Life Sciences, Artax Biopharma, AX-024 compound

Artax has validated the target and mechanism of action, and demonstrated preclinical proof of concept of AX-024 in various preclinical autoimmune disease (MS, Psoriasis, IBD, Type I diabetes) and GVHD...

Health & Bio Team Dating', a new initiative to bring together entrepreneurs and scientists

by Parc Científic de Barcelona

9 years ago
Health & Bio Team Dating, Barcelona Science Park (PCB), Biocat, CataloniaBio, Bosch i Gimpera Foundation (FBG), Banc Sabadell

Scientists and entrepreneurs will meet in short partnering meetings to combine their experience and projects with the aim of building a balanced team to lead successful start-up in the life sciences.

IBEC and B·Debate organize a scientific meeting on precision medicine and future tools for biomedical research

by Parc Científic de Barcelona

9 years ago
B·Debate, IBEC, precision medicine

The increasing costs of biomedical research and drug discovery and the continually rising numbers of compound failures provoke an urgent need for novel tools for basic research and preclinical testing...

Esteve signs agreement with VSY Biotechnology and enters the market for eye surgery

by Parc Científic de Barcelona

9 years ago
Esteve, VSY Biotechnology

This agreement allows Esteve to expand its portfolio in ophthalmology —which already includes products for ocular surface diseases and age-related macular degeneration (AMD)— and to address the su...

Leitat leads GLAM, a European project to improve cancer diagnosis

by Parc Científic de Barcelona

9 years ago
Genitourinary Cancer, GLAM project, Institute for Bioengineering of Catalonia (IBEC), Leitat

The members of the consortium will combine medical research with basic research and biotechnology to develop in a four-year term a new diagnostic tool to detect biomarkers from biofluids obtained in a...

Starts the clinical trial of a pioneering therapy for treating Multiple Sclerosis

by Parc Científic de Barcelona

9 years ago
Neuromyelitis Optica, multiple sclerosis, antigen-specific dendritic cell therapy

The clinical trial will be conducted July through December 2015 in 12 patients with multiple sclerosis. Subsequently trials will take place in Europe, and waiting inmid-2018 to get to the clinic if th...

SM Genomics will make available to the amateur athlete a genetic test which assesses susceptibility to injury

by Parc Científic de Barcelona

9 years ago
SM Genomics, susceptibility to injury, genetic test, amateur athlete

Starting from the patented technology, the biotech has developed the Genetic Injury Report (GIR) a complete medical-genetic assessment that allows to estimate the predisposition of the professional at...

SUMA agreement that will boost the PCB-PRBB Animal Facility Alliance is signed

by Parc Científic de Barcelona

9 years ago
PCB-PRBB Animal Facility Alliance, SUMA

PCB-PRBB Animal Facility Alliance" aims to improve the quality, competitiveness and sustainability of the support services for biomedical research in Catalonia, promote growth and ensure financial sta...

The Centro Nacional de Análisis Genómico integrates with the CRG to boost genome research in Barcelona

by Parc Científic de Barcelona

9 years ago
CNAG, CRG

Currently, CNAG has twelve last-generation sequencing systems with a sequencing capacity of over 1000 Gbases per day. It also has a powerful computer cluster (with 1250 processors and 2.7 petabytes of...

The UTOX of PCB renews GPL certificatIion and and it becomes one of the centers of reference in toxicology

by Parc Científic de Barcelona

9 years ago
toxicology

En 2011 consiguió ser el primer centro de investigación de ensayos ecotoxicològics del Estado español incluido en el programa de cumplimiento de los estándares de calidad de los principios Buenas...